10 Promising Therapeutic Vaccines

Scientists have long figured it would be possible to induce the immune system to attack tumors and fight diseases, but decades of work haven't yielded much--until now. FierceVaccines spotlights some vaccines currently being tested in humans and generating buzz. Report

Suggested Articles

Regeneron and Sanofi hope their PD-1 inhibitor Libtayo will be the first immuno-oncology treatment approved to treat basal cell carcinoma.

With its phase 3 trial moving right along, Moderna is expecting efficacy data in November—likely after Pfizer and BioNTech, but before everyone else.

Pfizer, GSK, BIO and others are all planning vaccine messages for fall.